EVO vs ICLR vs FTRE Stock Comparison

Evotec SE, Icon and Fortrea Holdings Prices as of Oct 26, 2026 Peers: Industry group
EVO Evotec SE
$1.52 -1.9% 1M -62.9% 1Y
Market cap
$555.82M
P/E
–
Revenue (TTM)
—
Div. yield
–
Contract Research Healthcare
1 win
ICLR Icon Plc
$183.78 +6.6% 1M +3.2% 1Y
Market cap
$14.35B
P/E
43.6x
Revenue (TTM)
$8.33B
Div. yield
–
Contract Research Healthcare
7 wins
FTRE Fortrea Holdings Inc.
$23.83 +19.8% 1M +110.9% 1Y
Market cap
$2.32B
P/E
–
Revenue (TTM)
$2.68B
Div. yield
–
Contract Research Healthcare
1 win

Head to Head

9 decided of 12

Icon leads on 7 of the 12 questions below (Icon 7, Fortrea Holdings 1, Evotec SE 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionEVOICLRFTRELeader
Larger companyMarket capitalisation $555.82M $14.35B $2.32B ICLR
Cheaper on earningsLower P/E, profitable companies only — 43.6x -27.2x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 17.9x 29.4x ICLR
Faster revenue growthRevenue growth, trailing twelve months — +3.7% -2.1% ICLR
More profitableNet margin, trailing twelve months — 3.9% -3.2% ICLR
Better return on capitalReturn on invested capital — 1.3% -0.7% ICLR
Less leveragedLower net debt / EBITDA — 3.5x 13.1x ICLR
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -62.9% +3.2% +110.9% FTRE
Better 5-year returnAnnualised price return, 5 years — -8.2%/yr — –
Less volatileAnnualised volatility, 1 year 58.0% 73.8% 70.4% EVO
Higher overall scoreMean of the five percentile scores vs peers — 69/100 55/100 ICLR

Percentile Scorecard

EVOICLRFTRE

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisEVOICLRFTRE
Valuation – 90 #2 of 11 100 #1 of 11
Growth – 30 #8 of 11 70 #4 of 11
Profitability – 80 #3 of 11 50 #6 of 11
Financial Health 92 #2 of 13 75 #4 of 13 0 #13 of 13
Shareholder Returns – – –
Overall – 69 55
  • EVO ranked among 13 companies in Pharma Services
  • ICLR ranked among 13 companies in Pharma Services
  • FTRE ranked among 13 companies in Pharma Services

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodEVOICLRFTRESPY
1 month -1.9%+6.6%+19.8% -0.8%
3 months -20.8%+8.9%+24.1% +3.5%
6 months -51.6%+78.1%+124.8% +7.0%
Year to date -50.6%+0.9%+38.1% +12.2%
1 year -62.9%+3.2%+110.9% +13.0%
3 years -81.8%-21.9%-13.4% +86.3%
3 years, per year -43.4%-7.9%-4.7% +23.1%
5 years —-34.8%— +68.6%
5 years, per year —-8.2%— +11.0%
10 years —+125.7%— +258.0%
10 years, per year —+8.5%— +13.6%

Risk

MeasureEVOICLRFTRESPY
Volatility, 1Y 58.0%73.8%70.4% 12.7%
Downside volatility, 1Y 65.3%87.9%63.6% 12.7%
Beta vs S&P 500, 1Y 1.491.452.00 1.00
Return / volatility, 1Y -1.080.041.57 1.02
Max drawdown, 5Y -94.6%-76.9%-89.9% -25.4%
From 52-week high -63.4%-9.4%-1.0% -1.8%
52-week high $4.15$202.92$24.06 $779.14
52-week low $1.35$80.08$8.87 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleEVOICLRFTRE
P/E now vs peer median —median 36.5x 43.8xmedian 36.5x -26.5xmedian 36.5x
P/S now vs peer median —median 2.7x 1.7xmedian 2.7x 0.8xmedian 2.7x
EV/EBITDA now vs peer median —median 37.7x 23.5xmedian 37.7x 46.7xmedian 37.7x
P/FCF now vs peer median —median 20.7x 15.9xmedian 20.7x 11.6xmedian 20.7x
P/B now vs peer median 0.7xmedian 2.9x 1.5xmedian 2.9x 4.3xmedian 2.9x
PEG now vs peer median —median 2.04 -3.55median 2.04 0.56median 2.04

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsEVOICLRFTRE
Revenue – $8.33B $2.68B
Gross profit – $2.01B $516.60M
Operating income – $325.64M -$10.80M
Net income – $69.55M -$85.20M
Free cash flow – $883.82M $196.00M
EPS (diluted) – $4.16 $-0.90
Cash & equivalents $397.89M $928.39M $168.60M
Total debt $1.96B $13.60B $1.05B
Shares (diluted) – 78.97M 94.80M
Enterprise value -$1.06B $11.46B $1.69B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricEVOICLRFTRE
P/E – 43.8x -26.5x
P/FCF – 15.9x 11.6x
P/Operating cash flow – 13.2x 9.9x
P/S – 1.7x 0.8x
P/B 0.7x 1.5x 4.3x
P/Tangible book 0.7x 2.3x -36.2x
EV/EBITDA – 23.5x 46.7x
EV/EBIT – 50.8x -291.8x
EV/Revenue – 2.0x 1.2x
EV/FCF – 18.7x 16.1x
EV/Operating cash flow – 15.5x 13.8x
PEG (3Y EPS CAGR) – -3.55 0.56

Growth

14 metrics
MetricEVOICLRFTRE
Revenue growth (1Y) – 3.7% -2.1%
Revenue CAGR (3Y) – 1.8% -0.1%
Gross profit growth (1Y) – -11.5% -4.2%
Gross profit CAGR (3Y) – -4.7% -10.2%
Operating income growth (1Y) – -66.6% 98.8%
Operating income CAGR (3Y) – -28.0% -27.7%
Net income growth (1Y) – -91.0% 91.7%
Net income CAGR (3Y) – -48.5% -38.4%
EPS growth (1Y) – -59.0% 92.1%
EPS CAGR (3Y) – -12.3% -47.7%
Operating cash flow growth (1Y) – -7.4% 359.7%
Operating cash flow CAGR (3Y) – 26.1% -3.4%
Free cash flow growth (1Y) – -10.7% 290.1%
Free cash flow CAGR (3Y) – 32.4% 0.8%

Profitability

14 metrics
MetricEVOICLRFTRE
Gross margin – 24.2% 19.3%
EBITDA margin – 8.4% 2.5%
Operating margin – 3.9% -0.4%
Pretax margin – 1.6% -2.9%
Net margin – 3.9% -3.2%
FCF margin – 10.6% 7.3%
Operating cash flow margin – 12.8% 8.5%
Return on equity – 6.4% -16.2%
Return on assets – 3.7% -3.2%
Return on invested capital – 1.3% -0.7%
Return on capital employed – 2.6% -0.6%
Asset turnover – 0.5x 1.0x
Cash conversion (OCF / net income) – 15.4x -2.7x
Stock comp / revenue – 1.4% 2.3%

Financial Health

11 metrics
MetricEVOICLRFTRE
Debt / assets 30.2% 20.7% 38.8%
Debt / equity 0.7x 0.4x 2.0x
Net debt / EBITDA – 3.5x 13.1x
Debt / FCF – 3.8x 5.4x
Liabilities / assets 57.7% 42.8% 80.7%
Equity / assets 42.3% 57.2% 19.3%
Interest coverage – 1.7x –
Current ratio 2.3x 1.0x 1.0x
Quick ratio 1.6x 0.6x 0.9x
Cash ratio 1.2x 0.2x 0.2x
Altman Z-score – 1.96 0.84

Shareholder Returns

7 metrics
MetricEVOICLRFTRE
Dividend yield – – –
Net buyback yield – 1.7% –
Shareholder yield 0.0% 1.7% –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusEVOICLRFTRE
Forward P/E – 17.9xFY2026 29.4xFY2026
EPS, next fiscal year $-0.72FY2026 $10.25FY2026 $0.81FY2026
EPS growth, next FY – -18.2%FY2026 +88.4%FY2026
EPS growth, the year after – +22.2% +22.2%
Revenue, next fiscal year $682.51MFY2026 $8.52BFY2026 $2.77BFY2026
Revenue growth, next FY -26.0%FY2026 +3.2%FY2026 +1.7%FY2026
Revenue growth, the year after +23.4% -3.2% -3.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersEVOICLRFTRE
Held by institutions 0.9% 100.0% 100.0%
Institutions holding 35 422 329
Change in shares held, QoQ -60.2% +5.5% -0.2%
Institutions buying 18 233 139
Institutions selling 7 138 108
Buyers to sellers 2.57 1.69 1.29

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

EVOICLRFTRE
EVO 1.00 0.21 0.19
ICLR 0.21 1.00 0.47
FTRE 0.19 0.47 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, EVO, ICLR and FTRE?

Icon (ICLR) is the largest by market capitalisation: Evotec SE (EVO) $555.82M, Icon (ICLR) $14.35B, Fortrea Holdings (FTRE) $2.32B.

Which company is growing faster?

Icon (ICLR) grew revenue fastest over the trailing twelve months: Icon (ICLR) +3.7%, Fortrea Holdings (FTRE) -2.1%.

Which company is more profitable?

Icon (ICLR) has the highest net margin (Icon (ICLR) 3.9%, Fortrea Holdings (FTRE) -3.2%). On return on invested capital, Icon (ICLR) leads (Icon (ICLR) 1.3%, Fortrea Holdings (FTRE) -0.7%).

Which stock has performed better?

Over the past year Fortrea Holdings (FTRE) returned the most: Evotec SE (EVO) -62.9%, Icon (ICLR) +3.2%, Fortrea Holdings (FTRE) +110.9%. Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Evotec SE (EVO) has been the steadiest (Evotec SE (EVO) 58.0%, Icon (ICLR) 73.8%, Fortrea Holdings (FTRE) 70.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, EVO, ICLR and FTRE?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Icon (ICLR) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.